Shire PLC (NASDAQ:SHPG)

160.08
Delayed Data
As of 4:00pm ET
 -4.29 / -2.61%
Today’s Change
123.73
Today|||52-Week Range
192.15
+3.20%
Year-to-Date
Shire's Tug of War
10:12am / GuruFocus News - Paid Partner Content
Why Is Allergan (AGN) Stock Falling Today?
Apr 19 / Zacks.com - Paid Partner Content
Shire (SHPG) Turns Down Takeda's Third Buyout Proposition
Apr 20 / Zacks.com - Paid Partner Content
The next mega merger could be a $60 billion drug deal
Apr 19 / CNNMoney.com
Biotech M&A Ratchets Up to a New Level
Apr 20 / GuruFocus News - Paid Partner Content
Sanofi to Divest European Generic Unit, Streamline Business
Apr 19 / Zacks.com - Paid Partner Content
GE earnings; Wells Fargo fine; Pound pummeled
Apr 20 / CNNMoney.com
Shire Sells Oncology Unit Ahead of Takeda's Potential Offer
Apr 17 / Zacks.com - Paid Partner Content
Takeda sweetens $60 billion Shire pitch as rival bows out
Apr 20 / CNNMoney.com
Shire (SHPG) is in Overbought Territory: What's Next?
Apr 10 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close164.37
Today’s open160.29
Day’s range158.50 - 161.50
Volume1,306,180
Average volume (3 months)1,425,737
Market cap$40.5B
Data as of 4:00pm ET, 04/23/2018

Growth & Valuation

Earnings growth (last year)+1,014.78%
Earnings growth (this year)+3.59%
Earnings growth (next 5 years)+5.41%
Revenue growth (last year)+35.39%
P/E ratio11.4
Price/Sales3.08
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...+0.54+0.34%
REGNRegeneron Pharmaceut...+1.76+0.56%
BAXBaxter International...+0.13+0.19%
ALXNAlexion Pharmaceutic...+0.05+0.05%
Data as of 4:00pm ET, 04/23/2018

Financials

Next reporting dateApril 26, 2018
EPS forecast (this quarter)$3.71
Annual revenue (last year)$15.3B
Annual profit (last year)$4.3B
Net profit margin28.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Flemming Ornskov
Chief Financial Officer &
Director
Thomas J. W. Dittrich
Corporate headquarters
Dublin, Dublin

Forecasts